Partner
Strategic partner
If your organisation has an asset, ambition or population that would benefit from clinically governed precision medicine, the first step is a conversation.
Partnerships
Enter the ecosystem through the right pathway.
Partners bring different assets — assays, innovations, patient populations, infrastructure. The engagement pathway is tailored, but every partnership follows the same six-stage roadmap.
Audience pathways
Who we partner with
We work with diagnostics and laboratory partners, innovators, healthcare providers, employers, technology partners and health systems.
Each partner brings a different asset — assays, innovations, patient populations, clinical infrastructure, workforce reach or AI-native technology. The engagement pathway is tailored around what you have and what you need.
Roadmap
From Discovery to Evidence & Improvement.
Every partnership progresses through the same stages, at a pace appropriate to the clinical context and organisational readiness.
- Stage 01Discovery
Educational conversation to understand context and ambition.
- Stage 02Strategic Assessment
Structured evaluation of programme fit, evidence and readiness.
- Stage 03Programme Design
Co-design of eligibility, protocol, oversight and outcomes.
- Stage 04Pilot
Governed pilot with defined success measures.
- Stage 05Implementation
Wider roll-out with clinical and operational scaling.
- Stage 06Evidence & Improvement
Longitudinal measurement feeding continuous refinement.
Begin
Every partnership begins as a conversation.
We prefer to understand your context before proposing anything. If GMG–GKIM is the right partner, we will say so. If we are not, we will say that too.